Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Clinical trial NCT04903314 · COMPLETED

Trial details

NCT number: NCT04903314
Sponsor: SK Life Science, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Partial Epilepsy

Start date: 2021-05-27
Primary completion: 2025-11-06
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.